• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

当代埃布斯坦畸形的管理：一个胎儿的故事及多方协作——病例报告

Management of Ebstein Anomaly in the Current Era: The Story of One Fetus and the Collaboration of Many-A Case Report.

作者信息

Kavanaugh-McHugh Ann, Zuckerwise Lisa C, Killen Stacy A S, Morris Emily A, Sullivan Rachel T, Alrifai Mhd Wael, Bichell David P, Smith-Parrish Melissa, Freud Lindsay

机构信息

Thomas. P. Graham Jr. Division of Pediatric Cardiology, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

出版信息

J Cardiovasc Dev Dis. 2024 May 9;11(5):147. doi: 10.3390/jcdd11050147.

DOI:10.3390/jcdd11050147
PMID:38786969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11122070/
Abstract

Collaborative multicenter research has significantly increased our understanding of fetal Ebstein anomaly, delineating risk factors for adverse outcomes as well as predictors of postnatal management. These data are incorporated into prenatal care and therapeutic strategies and inform family counseling and delivery planning to optimize care. This report details the translation of findings from multicenter studies into multidisciplinary prenatal care for a fetus with Ebstein anomaly, supraventricular tachycardia, and a circular shunt, including transplacental therapy to control arrhythmias and achieve ductal constriction, informed and coordinated delivery room management, and planned univentricular surgical palliation.

摘要

多中心合作研究显著增进了我们对胎儿埃布斯坦畸形的理解，明确了不良结局的风险因素以及产后管理的预测指标。这些数据被纳入产前护理和治疗策略中，并为家庭咨询和分娩计划提供依据，以优化护理。本报告详细介绍了将多中心研究结果转化为针对患有埃布斯坦畸形、室上性心动过速和环状分流的胎儿的多学科产前护理，包括经胎盘治疗以控制心律失常并实现动脉导管收缩、明智且协调的产房管理，以及计划性单心室手术姑息治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/1e5c0e06dfb8/jcdd-11-00147-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/21fa15ce39b1/jcdd-11-00147-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/8c165f56f305/jcdd-11-00147-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/59b67d8b374c/jcdd-11-00147-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/71186aeb32dd/jcdd-11-00147-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/1e5c0e06dfb8/jcdd-11-00147-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/21fa15ce39b1/jcdd-11-00147-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/8c165f56f305/jcdd-11-00147-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/59b67d8b374c/jcdd-11-00147-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/71186aeb32dd/jcdd-11-00147-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e382/11122070/1e5c0e06dfb8/jcdd-11-00147-g005.jpg

相似文献

1
Management of Ebstein Anomaly in the Current Era: The Story of One Fetus and the Collaboration of Many-A Case Report.当代埃布斯坦畸形的管理：一个胎儿的故事及多方协作——病例报告
J Cardiovasc Dev Dis. 2024 May 9;11(5):147. doi: 10.3390/jcdd11050147.
2
Effect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly).宫内非甾体类抗炎药治疗重度埃布斯坦畸形或三尖瓣发育不良（胎儿埃布斯坦畸形的 NSAID 治疗）。
Am J Cardiol. 2021 Feb 15;141:106-112. doi: 10.1016/j.amjcard.2020.11.013. Epub 2020 Nov 18.
3
Outcomes and Predictors of Perinatal Mortality in Fetuses With Ebstein Anomaly or Tricuspid Valve Dysplasia in the Current Era: A Multicenter Study.当代埃布斯坦畸形或三尖瓣发育异常胎儿围产期死亡率的结局及预测因素：一项多中心研究
Circulation. 2015 Aug 11;132(6):481-9. doi: 10.1161/CIRCULATIONAHA.115.015839. Epub 2015 Jun 9.
4
Impact of fetal haemodynamics on surgical and neurodevelopmental outcomes in patients with Ebstein anomaly and tricuspid valve dysplasia.胎儿血液动力学对埃布斯坦畸形伴三尖瓣发育不良患者手术和神经发育结局的影响。
Cardiol Young. 2022 Nov;32(11):1768-1779. doi: 10.1017/S1047951121004935. Epub 2022 Jan 6.
5
Risk Factors for Mortality and Circulatory Outcome Among Neonates Prenatally Diagnosed With Ebstein Anomaly or Tricuspid Valve Dysplasia: A Multicenter Study.产前诊断为埃布斯坦畸形或三尖瓣发育不良的新生儿的死亡率和循环结局的危险因素：一项多中心研究。
J Am Heart Assoc. 2020 Nov 3;9(21):e016684. doi: 10.1161/JAHA.120.016684. Epub 2020 Oct 20.
6
Critical Ebstein anomaly in a fetus successfully managed by elective preterm delivery and surgical intervention without delay after birth.胎儿严重型埃布斯坦畸形经选择性早产及出生后立即进行手术干预成功治疗。
Pediatr Cardiol. 2012 Feb;33(2):343-6. doi: 10.1007/s00246-011-0124-4. Epub 2011 Sep 25.
7
Current surgical therapy for Ebstein anomaly in neonates.新生儿埃布斯坦畸形的当前外科治疗方法。
J Thorac Cardiovasc Surg. 2006 Dec;132(6):1285-90. doi: 10.1016/j.jtcvs.2006.08.044. Epub 2006 Oct 30.
8
Transplacental non-steroidal anti-inflammatory drugs versus expectant management in fetal Ebstein anomaly with circular shunt: Systematic review and meta-analysis.经胎盘使用非甾体类抗炎药与期待治疗对伴有环形分流的胎儿埃布斯坦畸形：系统评价和荟萃分析。
Prenat Diagn. 2024 Jun;44(6-7):773-782. doi: 10.1002/pd.6446. Epub 2023 Oct 30.
9
[Circular shunting of blood: a complication of neonatal Ebstein anomaly].[血液的环状分流：新生儿埃布斯坦畸形的一种并发症]
Arch Pediatr. 2010 Dec;17(12):1673-6. doi: 10.1016/j.arcped.2010.08.023. Epub 2010 Nov 11.
10
An unusual ultrasonographic manifestation of a fetal Ebstein anomaly.胎儿埃布斯坦畸形的一种罕见超声表现。
Obstet Gynecol Sci. 2014 Nov;57(6):530-3. doi: 10.5468/ogs.2014.57.6.530. Epub 2014 Nov 20.

引用本文的文献

1
Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early-Onset Lysosomal Storage Diseases.对受早发性溶酶体贮积病影响的胎儿进行酶替代疗法的产前给药。
Am J Med Genet C Semin Med Genet. 2025 Jan 31:e32132. doi: 10.1002/ajmg.c.32132.

本文引用的文献

1
Prenatal Diagnosis of Congenital Heart Disease: The Crucial Role of Perinatal and Delivery Planning.先天性心脏病的产前诊断：围产期及分娩计划的关键作用
J Cardiovasc Dev Dis. 2024 Mar 31;11(4):108. doi: 10.3390/jcdd11040108.
2
Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric & Congenital Electrophysiology Society (PACES).胎儿和新生儿期心律失常的药理学处理：美国心脏协会的科学声明：得到儿科和先天性电生理学学会（PACES）的认可。
Circulation. 2024 Mar 5;149(10):e937-e952. doi: 10.1161/CIR.0000000000001206. Epub 2024 Feb 5.
3
Transplacental non-steroidal anti-inflammatory drugs versus expectant management in fetal Ebstein anomaly with circular shunt: Systematic review and meta-analysis.
经胎盘使用非甾体类抗炎药与期待治疗对伴有环形分流的胎儿埃布斯坦畸形：系统评价和荟萃分析。
Prenat Diagn. 2024 Jun;44(6-7):773-782. doi: 10.1002/pd.6446. Epub 2023 Oct 30.
4
Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography.胎儿超声心动图检查指南与建议：美国超声心动图学会的更新内容
J Am Soc Echocardiogr. 2023 Jul;36(7):679-723. doi: 10.1016/j.echo.2023.04.014. Epub 2023 May 24.
5
Fetal Arrhythmia Diagnosis and Pharmacologic Management.胎儿心律失常的诊断与药物治疗。
J Clin Pharmacol. 2022 Sep;62 Suppl 1(Suppl 1):S53-S66. doi: 10.1002/jcph.2129.
6
Evidence-Based Guidelines for Acute Stabilization and Management of Neonates with Persistent Pulmonary Hypertension of the Newborn.证据为基础的指南：新生儿持续肺动脉高压的急性稳定化和管理。
Am J Perinatol. 2023 Oct;40(14):1495-1508. doi: 10.1055/a-1711-0778. Epub 2021 Dec 1.
7
Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.新生儿持续性肺动脉高压的病理生理学和治疗管理。
Clin Perinatol. 2021 Aug;48(3):595-618. doi: 10.1016/j.clp.2021.05.009.
8
Extracardiac Doppler indices predict perinatal mortality in fetuses with Ebstein anomaly and tricuspid valve dysplasia.心脏外多普勒指数预测 Ebstein 畸形和三尖瓣发育不良胎儿的围产儿死亡率。
Prenat Diagn. 2021 Feb;41(3):332-340. doi: 10.1002/pd.5873. Epub 2021 Jan 9.
9
Effect of In Utero Non-Steroidal Anti-Inflammatory Drug Therapy for Severe Ebstein Anomaly or Tricuspid Valve Dysplasia (NSAID Therapy for Fetal Ebstein anomaly).宫内非甾体类抗炎药治疗重度埃布斯坦畸形或三尖瓣发育不良（胎儿埃布斯坦畸形的 NSAID 治疗）。
Am J Cardiol. 2021 Feb 15;141:106-112. doi: 10.1016/j.amjcard.2020.11.013. Epub 2020 Nov 18.
10
Risk Factors for Mortality and Circulatory Outcome Among Neonates Prenatally Diagnosed With Ebstein Anomaly or Tricuspid Valve Dysplasia: A Multicenter Study.产前诊断为埃布斯坦畸形或三尖瓣发育不良的新生儿的死亡率和循环结局的危险因素：一项多中心研究。
J Am Heart Assoc. 2020 Nov 3;9(21):e016684. doi: 10.1161/JAHA.120.016684. Epub 2020 Oct 20.